Jason A Konner Selected Research

mirvetuximab soravtansine

8/2018	Leveraging PET to image folate receptor α therapy of an antibody-drug conjugate.
1/2018	A review of mirvetuximab soravtansine in the treatment of platinum-resistant ovarian cancer.
11/2017	Characterization of folate receptor alpha (FRα) expression in archival tumor and biopsy samples from relapsed epithelial ovarian cancer patients: A phase I expansion study of the FRα-targeting antibody-drug conjugate mirvetuximab soravtansine.
4/2017	Safety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: A Phase I Expansion Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jason A Konner Research Topics

Disease

18	Ovarian Neoplasms (Ovarian Cancer) 07/2022 - 12/2011
17	Neoplasms (Cancer) 06/2022 - 04/2008
4	Hypertension (High Blood Pressure) 07/2022 - 12/2011
4	Ovarian Epithelial Carcinoma 11/2017 - 06/2008
2	Carcinoma (Carcinomatosis) 01/2022 - 01/2021
2	Endometrial Neoplasms (Endometrial Cancer) 08/2021 - 12/2017
2	Nausea 08/2017 - 02/2016
1	Sarcoma (Soft Tissue Sarcoma) 01/2022
1	Adenocarcinoma 08/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2020
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 01/2020
1	Microsatellite Instability 12/2018
1	Genetic Predisposition to Disease (Genetic Predisposition) 12/2017
1	Anemia 08/2017
1	B-Cell Lymphoma (Lymphoma, B Cell) 08/2017
1	Lymphoma (Lymphomas) 08/2017
1	Hyperhidrosis 08/2017
1	Multiple Myeloma 08/2017
1	Uterine Neoplasms (Uterine Cancer) 11/2016
1	Asthenia 02/2016
1	Diarrhea 02/2016
1	Disease Progression 02/2016
1	Abdominal Pain (Pain, Abdominal) 02/2016
1	Constipation 02/2016
1	Exanthema (Rash) 10/2012
1	Malignant Pleural Effusion 06/2008

Drug/Important Bio-Agent (IBA)

6	Bevacizumab (Avastin)FDA Link 07/2022 - 12/2011
6	PlatinumIBA 10/2021 - 11/2010
4	Immunoconjugates (Immunoconjugate)IBA 06/2022 - 04/2017
4	Immune Checkpoint InhibitorsIBA 01/2022 - 10/2019
4	Folate Receptor 1IBA 01/2020 - 11/2010
4	mirvetuximab soravtansineIBA 08/2018 - 04/2017
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2016
3	Monoclonal AntibodiesIBA 12/2017 - 11/2010
2	VaccinesIBA 07/2022 - 01/2020
2	Pharmaceutical PreparationsIBA 06/2022 - 10/2020
2	B7-H1 AntigenIBA 01/2022 - 10/2020
2	pembrolizumabIBA 08/2021 - 10/2020
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 12/2018
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020 - 08/2017
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 12/2011
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 12/2011
2	Folic Acid (Vitamin M)FDA LinkGeneric 08/2018 - 11/2010
2	farletuzumabIBA 11/2010 - 04/2008
1	Combined VaccinesIBA 07/2022
1	AntigensIBA 07/2022
1	Cathepsin KIBA 01/2022
1	Hormones (Hormone)IBA 01/2022
1	MART-1 AntigenIBA 01/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	Carboplatin (JM8)FDA LinkGeneric 10/2021
1	lenvatinibIBA 08/2021
1	atezolizumabIBA 10/2020
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2020
1	durvalumabIBA 01/2020
1	olaparibIBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2017
1	veliparibIBA 08/2017
1	Rituximab (Mabthera)FDA Link 08/2017
1	Bendamustine Hydrochloride FDA Link 08/2017
1	Alkylating AgentsIBA 08/2017
1	Maytansine (Maitansine)IBA 04/2017
1	TubulinIBA 04/2017
1	Hemoglobins (Hemoglobin)IBA 02/2016
1	taxaneIBA 02/2016
1	iniparibIBA 02/2016
1	MTOR InhibitorsIBA 10/2012
1	TOR Serine-Threonine KinasesIBA 10/2012
1	Everolimus FDA Link 10/2012
1	temsirolimus FDA Link 10/2012
1	IodidesIBA 04/2008
1	Therapeutic UsesIBA 04/2008

Therapy/Procedure

8	Therapeutics 10/2019 - 06/2008
5	Drug Therapy (Chemotherapy) 10/2020 - 06/2008
4	Neoadjuvant Therapy 01/2021 - 01/2020
1	Cytoreduction Surgical Procedures 10/2021
1	Hyperthermic Intraperitoneal Chemotherapy 10/2021
1	Immunotherapy 10/2019
1	Hysterectomy 11/2016
1	Salpingo-oophorectomy 11/2016
1	Adjuvant Chemotherapy 06/2013
1	Pelvic Exenteration 06/2013
1	Drug Tapering 10/2012
1	Radioimmunotherapy 04/2008